Effectiveness and Safety of Single Lower Limb Rehabilitation Training Robot in Stroke Patients With Hemiplegia

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05360017
Collaborator
(none)
92
1
1
12
7.7

Study Details

Study Description

Brief Summary

This trial is a multi center, randomized, controlled, excellent effect, open and loading trial design. The subjects are randomly assigned to the experimental group and the control group. The experimental group adopts litestepper single lower limb rehabilitation training robot walking training on the basis of routine rehabilitation management of stroke patients with hemiplegia, walking training once a day, 40 ± 5 minutes each time; The control group was treated with routine rehabilitation management of stroke patients with hemiplegia. The trial was an open design. Both researchers and subjects knew the treatment allocation and conducted three evaluations within 21 days to evaluate the effectiveness and safety of litestepper single lower limb rehabilitation training robot in the training of lower limb motor function of stroke patients with hemiplegia.

Condition or Disease Intervention/Treatment Phase
  • Device: litestepper single lower limb rehabilitation training robot
N/A

Detailed Description

By collecting the movement gait information of the patient's healthy side limb, judging the patient's movement intention, analyzing and learning the gait characteristics of the patient's healthy side, so as to drive the movement of the single lower limb rehabilitation training robot and drive the patient's affected side limb to carry out the rehabilitation training suitable for the healthy side limb, which can enable the patient to complete the normal walking process and achieve the purpose of auxiliary rehabilitation. Through long-term walking rehabilitation, patients can gradually recover their normal walking gait.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
92 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
multicenter, randomized, controlled, excellent effect, open trial designmulticenter, randomized, controlled, excellent effect, open trial design
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Clinical Trial to Evaluate the Effectiveness and Safety of Single Lower Limb Rehabilitation Training Robot in Lower Limb Motor Function Training of Stroke Patients With Hemiplegia
Actual Study Start Date :
Dec 2, 2021
Anticipated Primary Completion Date :
Dec 2, 2022
Anticipated Study Completion Date :
Dec 2, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Robot in lower limb motor function training of stroke patients with hemiplegia

Test equipment: litestepper single lower limb rehabilitation training robot Device type: Class II medical device

Device: litestepper single lower limb rehabilitation training robot
The experimental group adopts litestepper single lower limb rehabilitation training robot walking training on the basis of routine rehabilitation management of stroke patients with hemiplegia, walking training once a day, 40 ± 5 minutes each time; The control group was treated with routine rehabilitation management of stroke patients with hemiplegia. The trial was an open design. Both researchers and subjects knew the treatment allocation and conducted three evaluations within 21 days to evaluate the effectiveness and safety of litestepper single lower limb rehabilitation training robot in the training of lower limb motor function of stroke patients with hemiplegia.

Outcome Measures

Primary Outcome Measures

  1. The Berg balance scale [Visit three (Day 21 ± 2 )]

    Berg balance scale .The highest score is 56 points and the lowest score is 0 points. The higher the score, the stronger the balance ability. A score of less than 40 indicates a risk of falling.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • understand the whole process of the experiment, voluntarily participate and sign the informed consent;

  • 18-75 years old for both sexes;

  • Stable vital signs, stable condition, tolerance to low-intensity sitting and standing training;

④ Weight ≤ 100kg, height 1.50M ~ 1.90m;

⑤ Patients with stroke hemiplegia diagnosed as the first onset, including cerebral infarction and intracerebral hemorrhage, the course of disease is within one month after the onset;

⑥ One level of sitting or standing balance, able to wear a single lower limb rehabilitation training robot with the help of medical staff;

⑦ The passive range of motion of hip and knee is not significantly limited, and the passive range of ankle can be kept in neutral position.

Exclusion Criteria:
  • The range of motion of the joint is severely limited and the walking movement is limited;

  • Skin injury or infection of the lower limb in contact with the robot;

  • History of unstable angina pectoris, severe arrhythmia and other heart diseases;

④ History of severe chronic obstructive pulmonary disease;

⑤ Other contraindications or complications that may affect walking training;

⑥ Pregnant women, women preparing for pregnancy or lactation;

⑦ Those who participated in any clinical trial within 1 month before enrollment;

⑧ Other circumstances that the researcher believes cannot participate in the clinical trial.

Contacts and Locations

Locations

Site City State Country Postal Code
1 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China Hangzhou Zhejiang China 310009

Sponsors and Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

Investigators

  • Principal Investigator: Ying Jin, Master, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Second Affiliated Hospital, School of Medicine, Zhejiang University
ClinicalTrials.gov Identifier:
NCT05360017
Other Study ID Numbers:
  • 2021-230
First Posted:
May 4, 2022
Last Update Posted:
May 4, 2022
Last Verified:
Oct 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Second Affiliated Hospital, School of Medicine, Zhejiang University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 4, 2022